Physician profile
Mihai Croitoru
NPI 1932192309
$8,805.52
in general payments reported to CMS, 2019-2025
34 companies · $503 in 2025
The $503 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,752 · 2020: $315 · 2021: $776 · 2022: $1,281 · 2023: $1,166 · 2024: $1,012 · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,681.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,615.33 | 2019-2025 | Triclip, Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Amgen INC. | $1,450.42 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $578.69 | 2019-2025 | Wainua, Farxiga, Brilinta |
| Novartis Pharmaceuticals Corporation | $523.87 | 2019-2025 | |
| Boston Scientific Corporation | $480.28 | 2022-2024 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Janssen Pharmaceuticals, INC | $366.49 | 2019-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $353.49 | 2019-2024 | |
| Pfizer INC. | $334.61 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $325.72 | 2019-2025 | Jardiance |
| Medtronic, INC. | $265.17 | 2021-2023 | Linq II |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $231.01 | 2019-2025 | Lifevest |
| Lundbeck LLC | $151.39 | 2019-2020 | |
| Irhythm Technologies, INC. | $113.35 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $107.86 | 2022-2023 | |
| Kiniksa Pharmaceuticals International, Plc | $105.55 | 2024 | Arcalyst |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $101.06 | 2023-2024 | Inpefa |
| E.R. Squibb & Sons, L.L.C. | $92.30 | 2019-2022 | |
| Abiomed | $74.51 | 2024-2025 | Impella |
| Regeneron Healthcare Solutions, INC. | $68.08 | 2019 | |
| Alnylam Pharmaceuticals INC. | $66.47 | 2023-2024 | Onpattro |
| Esperion Therapeutics, INC. | $57.74 | 2021-2024 | Nexletol |
| Gilead Sciences, INC. | $49.15 | 2019 | |
| Chiesi USA, INC. | $46.49 | 2019-2023 | Kengreal |
| Cvrx, INC. | $30.51 | 2023 | Barostim Neo System |
| Teleflex LLC | $28.09 | 2022-2023 | Turnpike |
| Merck Sharp & Dohme LLC | $26.87 | 2021-2022 | |
| Biotronik INC. | $24.19 | 2020 | |
| Portola Pharmaceuticals, LLC | $23.35 | 2019 | |
| Edwards Lifesciences Corporation | $23.02 | 2023 | Pascal |
| Zoll Circulation INC | $21.30 | 2025 | Downstream Cartridge, Therox Ds2 Console, Catheter |
| Medtronic Vascular, INC. | $20.15 | 2020 | |
| Kestra Medical Technology Services, INC. | $18.25 | 2024 | Assure Wcd |
| Actelion Pharmaceuticals US, INC. | $16.62 | 2023 | Opsumit, Uptravi |
| Amarin Pharma, INC. | $14.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mihai Croitoru listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.